ACC Chief Innovation Officer Dr. Ami Bhatt hosts electrophysiologists Drs. Alexandre Almorad and Christopher Porterfield in this CardiaCast episode to dissect cutting-edge pulsed field ablation (PFA) innovations for atrial fibrillation (AFib). Highlight PFA's non-thermal electroporation mechanism , which selectively ablates cardiomyocytes while sparing esophagus, phrenic nerve, and coronary arteries, slashing risks of thermal ablation complications like fistulas or palsy.
Drawing from 2025 trials, the discussion covers durable pulmonary vein isolation efficacy, arrhythmia recurrence rates under 20% at one year, procedural efficiency gains, and real-world implementation barriers for cardiologists. Join ACC innovators as they decode P FA's transformative potential for safer, faster AFib ablation in your practice. To access the podcast: Click here ##Reference## Bhatt A, Almorad A,…
